Tokyo, Dec. 1 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000059539) titled 'Improvement Effects of Intake of Resveratrol-containing Extracts from the Indian traditional medicine Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch' on Dec. 1.
Study Type:
Interventional
Study Design:
Basic Design - Parallel
Randomization - Randomized
Blinding - Double blind -all involved are blinded
Control - Placebo
Primary Sponsor:
Institute - Specified Nonprofit Organization Japanese Center for Anti-Aging Medical Sciences
Condition:
Condition - Skin Blotch
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - It is clinically examined whether Improvement Effects of Intake of Resveratrol-containing Extracts from Pterocarpus marsupiumand and Red Wine Combined with Palmitoyl Vitamin C on Human Skin Blotch.
Basic objectives2 - Efficacy
Intervention:
Interventions/Control_1 - Placebo. Intervention by administration for 30 days at a dose of 500-550 mg per one subject, once for a day.
Interventions/Control_2 - Vitamin C Palmitate. Intervention by administration for 30 days at a dose of 500-550 mg per one subject, once for a day.
Eligibility:
Age-lower limit - 27
years-old
=
Gender - Male and Female
Key inclusion criteria - No diseases, Japanese persons, normal blotch degrees in face and sun-exposed skin.
Key exclusion criteria - Persons with some serious disease. Underage and highly elder.
Target Size - 12
Recruitment Status:
Recruitment status - No longer recruiting
Date of protocol fixation - 2024 Year 02 Month 01 Day
Date of IRB - 2024 Year 06 Month 01 Day
Anticipated trial start date - 2024 Year 06 Month 20 Day
Last follow-up date - 2025 Year 09 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067917
Disclaimer: Curated by HT Syndication.
